An Untapped Resource: Pharmacists’ Role in Improving Screening and Management of NVAF

Download All
Experts discuss the role of pharmacists in the screening of nonvalvular atrial fibrillation in 4 microlearning module presentations. Key points about disease burden, screening, management, and adherence are illustrated with a patient case and demonstration of a clinical visit with a patient and pharmacist. Learners can review information with an infographic, podcast, and downloadable slidesets.
Stephanie Dwyer Kaluzna, PharmD, BCCP
Kathleen A. Lusk, PharmD, BCPS, BCCP

Microlearning Modules

In this microlearning module, an expert faculty provides an overview of the prevalence, burden, and consequences of undiagnosed NVAF.

Stephanie Dwyer Kaluzna, PharmD, BCCP Kathleen A. Lusk, PharmD, BCPS, BCCP Pharmacists: 0.25 contact hours (0.025 CEUs) Released: April 12, 2022 Expired: April 11, 2023

In this microlearning module, an expert faculty provides insight on screening for NVAF in pharmacy settings.

Stephanie Dwyer Kaluzna, PharmD, BCCP Kathleen A. Lusk, PharmD, BCPS, BCCP Pharmacists: 0.25 contact hours (0.025 CEUs) Released: April 12, 2022 Expired: April 11, 2023

In this microlearning module, an expert faculty provides evidence-based recommendations on the use of DOAC therapy in NVAF for stroke prevention.

Stephanie Dwyer Kaluzna, PharmD, BCCP Kathleen A. Lusk, PharmD, BCPS, BCCP Pharmacists: 0.5 contact hours (0.05 CEUs) Released: April 13, 2022 Expired: April 12, 2023

In this microlearning module, an expert faculty discusses best practices in engaging patients and the healthcare team in collaborative, shared-decision making.

Stephanie Dwyer Kaluzna, PharmD, BCCP Kathleen A. Lusk, PharmD, BCPS, BCCP Pharmacists: 0.5 contact hours (0.05 CEUs) Released: April 12, 2022 Expired: April 11, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings